Feature Channels: Infectious Diseases

Filters close
access_time Embargo lifts in 2 days
This news release is embargoed until 24-Oct-2024 8:00 AM EDT Released to reporters: 18-Oct-2024 8:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Oct-2024 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 17-Oct-2024 7:45 AM EDT
Penn Medicine and Children’s Hospital of Philadelphia Create mRNA Vaccine to Prevent and Treat C. difficile
Perelman School of Medicine at the University of Pennsylvania

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile or C. diff. In animal models, this first mRNA-LNP C. difficile vaccine was found to protect against C. difficile first-time infections and relapsing infections by inducing a robust immune response, promote clearance of existing C. diff bacteria from the gut, and even overcome deficits in host immunity to protect animals after infection.

Newswise: Study Finds HIV-To-HIV Kidney Transplants Are as Safe and Effective as Those Using Organs From Donors Without HIV
Released: 16-Oct-2024 5:15 PM EDT
Study Finds HIV-To-HIV Kidney Transplants Are as Safe and Effective as Those Using Organs From Donors Without HIV
Johns Hopkins Medicine

According to findings from a multicenter study led by Johns Hopkins Medicine and released today in The New England Journal of Medicine (NEJM), transplanting kidneys from deceased donors who had the human immunodeficiency virus (HIV) to recipients with HIV is safe. Perhaps more importantly, the study authors also found that HIV-to-HIV kidney transplants are comparable in effectiveness to those using organs from donors without HIV.

Newswise:Video Embedded rsv-recommendations-preventatives-for-fall-2024
VIDEO
Released: 16-Oct-2024 4:15 PM EDT
RSV recommendations & preventatives for Fall 2024
Corewell Health

Corewell Health physicians offer expert advice on RSV and how to prevent serious illness this fall and winter. https://vimeo.com/1014594403/a43d6d1676?share=copy

Released: 16-Oct-2024 3:50 PM EDT
COVID-19 Study Reveals Virus-Induced Inflammation During Pregnancy, Redefines Vertical Transmission
Cleveland Clinic

A Cleveland Clinic-led study published in The EMBO Journal shows that mild and asymptomatic SARS-CoV-2 infections can trigger immune responses in a pregnant individual that may cause serious inflammatory responses in the developing fetus.

8-Oct-2024 4:55 PM EDT
Mount Sinai Doctors to Present at ID Week 2024
Mount Sinai Health System

Experts in infection prevention and control available for interview about research findings and other breaking health topics including the flu, COVID, HIV, mpox, West Nile, and vaccinations

Newswise:Video Embedded the-family-that-gets-vaccinated-together-stays-healthy-together
VIDEO
Released: 15-Oct-2024 2:20 PM EDT
The Family That Gets Vaccinated Together, Stays Healthy Together
Cedars-Sinai

As flu season ramps up, infectious disease experts at Cedars-Sinai are urging everyone in the community, from infants on up, to get their flu shots.

Released: 15-Oct-2024 12:00 PM EDT
Another Reason to Vaccinate Teens Against HPV
Tufts University

Oral pathologist explains the origins of HPV vaccine reluctance; the benefits of vaccination; and how people who came of age before it arrived can still protect themselves from HPV-related cancers.

Newswise: $7 Million From ARPA-H to Tackle Lung Infections Through Innovative Probiotic Treatment
Released: 10-Oct-2024 7:05 PM EDT
$7 Million From ARPA-H to Tackle Lung Infections Through Innovative Probiotic Treatment
University of California San Diego

UC San Diego has received a $7 million ARPA-H contract for the PROTECT project, targeting pathogens like Pseudomonas aeruginosa and Staphylococcus aureus. These pathogens pose serious health risks to individuals with cystic fibrosis and those reliant on respirators.

Released: 10-Oct-2024 12:00 PM EDT
Travel Advisory Issued for Rwanda Due to Outbreak of Deadly Marburg Virus Disease
George Washington University

An outbreak of the Marburg virus in Rwanda has prompted public health officials to announce they will start screening travelers to the US who have also been in Rwanda in the last 21 days. The George... ...

Newswise: Expert Alert: San Diego Scientist Available to Comment on Local Dengue Case
Released: 10-Oct-2024 11:05 AM EDT
Expert Alert: San Diego Scientist Available to Comment on Local Dengue Case
La Jolla Institute for Immunology

LA JOLLA, CA—La Jolla Institute for Immunology (LJI) Professor Sujan Shresta, Ph.D., is on hand to share her expertise on dengue fever and dengue vaccine development. She is available to comment on urgent dengue virus research amidst the news of San Diego’s first locally acquired dengue virus case. LJI Professor Sujan Shresta, Ph.

Newswise: Mount Sinai Opens State-of-the-Art Center for Patients With Complex Conditions Including Lyme Disease and Long COVID
8-Oct-2024 8:00 AM EDT
Mount Sinai Opens State-of-the-Art Center for Patients With Complex Conditions Including Lyme Disease and Long COVID
Mount Sinai Health System

The Cohen Center for Recovery From Complex Chronic Illnesses will also research new therapies for these conditions

Released: 9-Oct-2024 3:05 PM EDT
COVID-19 Recommendations for Fall 2024
Corewell Health

Fall is here and with it, comes cold and flu season. With schools back in session and people gathering inside more, COVID will also be a player in this year’s circulating respiratory viruses. Corewell Health’s infectious disease experts Dr. Russ Lampen and Dr. Nick Gilpin teamed up to answer the most frequently asked questions when it comes to this year’s COVID vaccine. You can download an edited package HERE: https://vimeo.com/1009923626/8089770e92?share=copy Or, put together your own story using raw footage HERE: https://vimeo.com/1010598326/33c7177fc1?share=copy Thank you for your consideration. Please feel free to reach out with any questions.

Newswise: History of COVID-19 Doubles Long-term Risk of Heart Attack, Stroke and Death
7-Oct-2024 9:05 AM EDT
History of COVID-19 Doubles Long-term Risk of Heart Attack, Stroke and Death
Cleveland Clinic

Cleveland: A history of COVID-19 can double the risk of heart attack, stroke or death according to new research led by Cleveland Clinic and the University of Southern California. The study found that people with any type of COVID-19 infection were twice as likely to have a major cardiac event, such as heart attack, stroke or even death, for up to three years after diagnosis.

Released: 8-Oct-2024 12:00 PM EDT
Taking Biodiversity in 'One Health' to the Next Level
Universite de Montreal

Timothée Poisot is named to a new global working group and 'knowledge-to-action' hub aiming to help the world better understand the role of biodiversity in outbreaks of infectious disease.

   
Released: 8-Oct-2024 9:05 AM EDT
Rates of a Tick-Borne Parasitic Disease Are on the Rise
Penn State College of Medicine

Rates of babesiosis, a tick-borne parasitic disease, increased an average of 9% per year in the United States between 2015 and 2022 and four in 10 patients were found to be co-infected with another tick-borne illness such as Lyme disease.



close
4.45829